Fetching results...
0 items found

A0268: Urinary comprehensive genomic profiling predicts urothelial cancer up to 12 years ahead of clinical diagnosis: An expanded analysis of the Golestan Cohort Study

Dr. F. (Florence) Le Calvez-Kelm
Le Calvez-Kelm F.1, Salari K.2, Feldman A.2, Sundi D.3, Lee J.J.2, Difiore G.3, Poustchi H.4, Khoshnia M.5, Roshandel G.5, Etemadi A.6, Goudarzi M.7, Lentz P.S.8, Phillips K.G.7, Bicocca V.T.8, Koppie T.M.9, Gray J.W.10, Levin T.G.7, Malekzadeh R.4, Lotan Y.11, Sheikh M.12
1International Agency for Research on Cancer, Genomic Epidemiology, Lyon, France, 2Massachusetts General Hospital, Dept. of Urology, Boston, United States of America, 3Ohio State University, Dept. of Urology, Columbus, United States of America, 4Tehran University of Medical Sciences, Digestive Disease Research Center, Tehran, Iran, 5Golestan University of Medical Sciences, Golestan Research Center of Gastroenterology and Hepatology, Gorgan, Iran, 6National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, United States of America, 7Convergent Genomics, Dept. of Data Science, South San Francisco, United States of America, 8Convergent Genomics, Clinical Laboratory, South San Francisco, United States of America, 9Willamette Urology, Dept. of Urology, Salem, United States of America, 10Oregon Health & Science University, Dept. of Biomedical Engineering, Portland, United States of America, 11UT Southwestern Medical Center, Dept. of Urology, Dallas, United States of America, 12International Agency For Research On Cancer, Dept. of Genomic Epidemiology, Lyon, France
38th Annual EAU Congress
Date – Time - Location
11 March 2023, 17:15 - 18:45, Yellow Area, Brown 3
Abstract Session 15 - Markers for improved diagnosis and outcome of non-muscle invasive bladder cancer
Urothelial Cancer, NMIBC - Screening
  • © 2023 European Association of Urology
  • Disclaimer